Terminology Service for NFDI4Health
all-cis-5,8,11,14,17-icosapentaenoic acid
Go to external page
http://purl.obolibrary.org/obo/CHEBI_28364
An icosapentaenoic acid having five cis-double bonds at positions 5, 8, 11, 14 and 17.
Term info
Label
all-cis-5,8,11,14,17-icosapentaenoic acid
Synonyms
- (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoic acid
Subsets
3_STAR
charge
0
formula
C20H30O2
has alternative id
CHEBI:4764, CHEBI:23901, CHEBI:42328
has obo namespace
chebi_ontology
has related synonym
cis-5,8,11,14,17-EPA, Icosapentaenoic acid, (5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-eicosapentaenoic acid, 5,8,11,14,17-EICOSAPENTAENOIC ACID, 5,8,11,14,17-Icosapentaenoic acid, (5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate, (5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid, cis-5,8,11,14,17-eicosapentaenoic acid, Timnodonic acid, icosapentum, all-cis-5,8,11,14,17-eicosapentaenoic acid, cis-Delta(5,8,11,14,17)-eicosapentaenoic acid, icosapento, EPA, all-cis-icosa-5,8,11,14,17-pentaenoic acid, (5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid, (all-Z)-5,8,11,14,17-eicosapentaenoic acid, icosapent, Eicosapentaenoic acid, cis, cis, cis, cis, cis-eicosa-5,8,11,14,17-pentaenoic acid
id
CHEBI:28364
inchi
InChI=1S/C20H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h3-4,6-7,9-10,12-13,15-16H,2,5,8,11,14,17-19H2,1H3,(H,21,22)/b4-3-,7-6-,10-9-,13-12-,16-15-
inchikey
JAZBEHYOTPTENJ-JLNKQSITSA-N
mass
302.45100
monoisotopicmass
302.22458
smiles
CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O
Term relations
Subclass of:
- icosapentaenoic acid
- omega-3 fatty acid
- has role some nutraceutical
- has role some mouse metabolite
- has role some antidepressant
- has role some antineoplastic agent
- has role some Daphnia galeata metabolite
- has role some anticholesteremic drug
- is conjugate acid of some all-cis-5,8,11,14,17-icosapentaenoate
- has role some micronutrient
- has role some fungal metabolite
Related from:
has functional parent
- (5Z,9E,11Z,14Z,17Z)-8-hydroperoxyicosapentaenoic acid
- 17(18)-EpETE
- 1-[(11Z)-octadecenoyl]-2-[(5Z,8Z,11Z,14Z,17Z)-eicosapentaenoyl]-sn-glycero-3-phosphocholine
- 1-[(9Z)-octadecenoyl]-2-[(5Z,8Z,11Z,14Z,17Z)-eicosapentaenoyl]-sn-glycero-3-phosphocholine
- 1-octadecanoyl-2-[(5Z,8Z,11Z,14Z,17Z)-eicosapentaenoyl]-sn-glycero-3-phosphocholine
- 1-[(5Z,8Z,11Z,14Z,17Z)-eicosapentaenoyl]-2-[(9Z)-octadecenoyl]-sn-glycero-3-phosphocholine
- 2-[(5Z,8Z,11Z,14Z,17Z)-eicosapentaenoyl]-sn-glycerol
- 1-hexadecanoyl-2-[(5Z,8Z,11Z,14Z,17Z)-icosapentaenoyl]-sn-glycero-3-phosphocholine
- 1-hexadecyl-2-[(5Z,8Z,11Z,14Z,17Z)-eicosapentaenoyl]-sn-glycero-3-phosphocholine
- (5Z,11Z,14Z,17Z)-8,9-epoxyicosatetraenoic acid
- 1-icosanoyl-2-[(5Z,8Z,11ZZ,14Z,17Z)-eicosapentaenoyl]-sn-glycerol
- (5Z,8Z,14Z,17Z)-11,12-epoxyicosatetraenoic acid
- (5Z,8Z,11Z,17Z)-14,15-epoxyicosatetraenoic acid
- (5Z,8Z,11Z,14Z,17Z)-icosapentaenoylethanolamine
- (6E,8Z,11Z,14Z,17Z)-5-oxoicosapentaenoic acid
- ethyl (5Z,8Z,11Z,14Z,17Z)-icosapentaenoate
- cholesteryl (5Z,8Z,11Z,14Z,17Z-eicosapentaenoate)
- (5Z,8Z,11Z,14Z,17Z)-icosapentaenoyl-containing glycerolipid
- 12-HPEPE
- 20-HEPE
- 19-HEPE
- 5,20-diHEPE
- (5Z,8Z,11Z,14Z,16E,18R)-18-hydroperoxyicosapentaenoic acid
- timnodonoyl bioconjugate
- 11-HEPE